CarsonAllaria Wealth Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $153K | Buy |
3,973
+14
| +0.4% | +$538 | 0.08% | 82 |
|
|
2025
Q1 | $153K | Buy |
3,959
+242
| +7% | +$9.38K | 0.09% | 83 |
|
|
2024
Q4 | $126K | Sell |
3,717
-289
| -7% | -$9.77K | 0.07% | 87 |
|
|
2024
Q3 | $164K | Buy |
4,006
+138
| +4% | +$5.64K | 0.09% | 76 |
|
|
2024
Q2 | $149K | Sell |
3,868
-461
| -11% | -$17.8K | 0.09% | 74 |
|
|
2024
Q1 | $186K | Sell |
4,329
-1,570
| -27% | -$67.3K | 0.12% | 68 |
|
|
2023
Q4 | $219K | Sell |
5,899
-1,216
| -17% | -$45.1K | 0.16% | 61 |
|
|
2023
Q3 | $258K | Buy |
7,115
+5,502
| +341% | +$199K | 0.21% | 52 |
|
|
2023
Q2 | $57.5K | Sell |
1,613
-3,636
| -69% | -$130K | 0.05% | 107 |
|
|
2023
Q1 | $187K | Buy |
5,249
+1,730
| +49% | +$61.6K | 0.16% | 69 |
|
|
2022
Q4 | $124K | Sell |
3,519
-1,362
| -28% | -$48K | 0.11% | 78 |
|
|
2022
Q3 | $144K | Buy |
+4,881
| New | +$144K | 0.13% | 76 |
|
|
2022
Q2 | – | Sell |
-128
| Closed | -$7K | – | 336 |
|
|
2022
Q1 | $7K | Hold |
128
| – | – | 0.01% | 216 |
|
|
2021
Q4 | $7K | Buy |
+128
| New | +$7K | 0.01% | 232 |
|